Analysts predict that Surgery Partners Inc (NASDAQ:SGRY) will announce earnings per share (EPS) of $0.06 for the current quarter, Zacks reports. Four analysts have made estimates for Surgery Partners’ earnings. The lowest EPS estimate is $0.01 and the highest is $0.13. Surgery Partners reported earnings of $0.19 per share in the same quarter last year, which would indicate a negative year-over-year growth rate of 68.4%. The firm is scheduled to announce its next quarterly earnings results on Thursday, March 8th.
According to Zacks, analysts expect that Surgery Partners will report full-year earnings of $0.06 per share for the current fiscal year, with EPS estimates ranging from $0.01 to $0.13. For the next year, analysts forecast that the company will post earnings of $0.27 per share, with EPS estimates ranging from $0.05 to $0.57. Zacks’ earnings per share averages are a mean average based on a survey of research firms that follow Surgery Partners.
Surgery Partners (NASDAQ:SGRY) last announced its earnings results on Wednesday, November 8th. The company reported ($0.04) earnings per share (EPS) for the quarter, beating the Thomson Reuters’ consensus estimate of ($0.11) by $0.07. Surgery Partners had a positive return on equity of 1.03% and a negative net margin of 0.33%.
Several research analysts recently issued reports on the company. Zacks Investment Research raised Surgery Partners from a “sell” rating to a “hold” rating in a research report on Saturday, January 13th. BidaskClub upgraded Surgery Partners from a “sell” rating to a “hold” rating in a research note on Wednesday, December 27th. Jefferies Group dropped their price target on Surgery Partners from $16.00 to $13.00 and set a “buy” rating on the stock in a research note on Wednesday, November 1st. ValuEngine downgraded Surgery Partners from a “hold” rating to a “sell” rating in a research note on Sunday, December 31st. Finally, KeyCorp reiterated a “hold” rating on shares of Surgery Partners in a research note on Friday, September 22nd. Two investment analysts have rated the stock with a sell rating, five have assigned a hold rating and four have assigned a buy rating to the stock. The company currently has a consensus rating of “Hold” and an average target price of $18.57.
Surgery Partners (NASDAQ SGRY) opened at $15.95 on Thursday. Surgery Partners has a 1 year low of $7.10 and a 1 year high of $24.05. The stock has a market capitalization of $741.29, a PE ratio of -34.67 and a beta of 1.88. The company has a debt-to-equity ratio of 1.56, a quick ratio of 1.92 and a current ratio of 2.09.
Surgery Partners announced that its Board of Directors has approved a share repurchase program on Friday, December 15th that authorizes the company to repurchase $50.00 million in outstanding shares. This repurchase authorization authorizes the company to buy shares of its stock through open market purchases. Stock repurchase programs are typically a sign that the company’s leadership believes its shares are undervalued.
Several institutional investors and hedge funds have recently modified their holdings of the company. Russell Investments Group Ltd. boosted its position in Surgery Partners by 211.4% during the second quarter. Russell Investments Group Ltd. now owns 11,915 shares of the company’s stock worth $271,000 after purchasing an additional 8,089 shares in the last quarter. Schwab Charles Investment Management Inc. boosted its position in Surgery Partners by 14.6% during the second quarter. Schwab Charles Investment Management Inc. now owns 75,721 shares of the company’s stock worth $1,723,000 after purchasing an additional 9,656 shares in the last quarter. Wells Fargo & Company MN boosted its position in Surgery Partners by 25.7% during the second quarter. Wells Fargo & Company MN now owns 499,712 shares of the company’s stock worth $11,368,000 after purchasing an additional 102,258 shares in the last quarter. Alliancebernstein L.P. boosted its position in Surgery Partners by 1.1% during the second quarter. Alliancebernstein L.P. now owns 28,400 shares of the company’s stock worth $646,000 after purchasing an additional 300 shares in the last quarter. Finally, Ameriprise Financial Inc. boosted its position in Surgery Partners by 0.3% during the second quarter. Ameriprise Financial Inc. now owns 229,575 shares of the company’s stock worth $5,223,000 after purchasing an additional 605 shares in the last quarter. Hedge funds and other institutional investors own 94.16% of the company’s stock.
About Surgery Partners
Surgery Partners, Inc is a healthcare services company. The Company operates in three lines of business across the United States: Surgical Facility Services, Ancillary Services and Optical Services. The Company’s Surgical Facility Services segment consists of the operation of ambulatory surgery centers (ASCs) and surgical hospitals, which include its anesthesia services.
For more information about research offerings from Zacks Investment Research, visit Zacks.com
Receive News & Ratings for Surgery Partners Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Surgery Partners and related companies with MarketBeat.com's FREE daily email newsletter.